Robotic arms take on breast cancer surgery: a new hope for nipple preservation?
NCT ID NCT05720039
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a robotic surgical system (da Vinci SP) to traditional open surgery for nipple-sparing mastectomy in women with early-stage breast cancer. The trial involves 204 participants and will measure safety, cancer recurrence, and patient satisfaction. The goal is to see if the robotic approach offers similar or better outcomes with potentially less scarring.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
da Vinci SP surgical system
What this could lead to
If successful, this could show that robotic nipple-sparing mastectomy is as safe and effective as open surgery, potentially offering a less invasive option for breast cancer patients.
What could go wrong
This is a relatively early-stage trial with 204 participants, so results may not apply to all patients. Robotic surgery may have higher costs or longer procedure times, and cancer recurrence rates will need long-term follow-up.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ascension St. Columbia Mary's
Milwaukee, Wisconsin, 53211, United States
-
Cedars-Sinai
Los Angeles, California, 940048, United States
-
City of Hope
Irvine, California, 92618, United States
-
Corewell
Detroit, Michigan, 48073, United States
-
Duke University
Durham, North Carolina, 27710, United States
-
Emory University
Atlanta, Georgia, 30342, United States
-
Endeavor Health
Evanston, Illinois, 60201, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Mayo Clinic Florida
Jacksonville, Florida, 32224, United States
-
Mayo Clinic Rochester
Rochester, Minnesota, 55902, United States
-
Northwell Health
Lake Success, New York, 11042, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19107, United States
-
University of Washington
Seattle, Washington, 98195, United States
-
Vanderbilt
Nashville, Tennessee, 37232, United States
-
Washington University, St. Louis
St Louis, Missouri, 63110, United States